GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹515 Cr | ₹456 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr |
What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹515 Cr |
| Mar2025 | ₹456 Cr |
| Mar2024 | ₹387 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹355 Cr |
How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹515 Cr | 12.92 | |
| Mar2025 | ₹456 Cr | 17.78 | |
| Mar2024 | ₹387 Cr | 9.46 | |
| Mar2023 | ₹354 Cr | -0.26 | |
| Mar2022 | ₹355 Cr | - | |
Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,318.2 Cr | -5.7% | -7.2% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -5.7% |
-7.2% |
3.9% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses